市場調查報告書
商品編碼
1197243
孵化器設備市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)Incubator Devices Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內,孵化器設備市場的複合年增長率預計為 6.9%。
COVID-19 的不利影響和早產率的增加推動了對孵化器設備的需求,這對市場增長產生了重大影響。 根據 JAMA 於 2021 年 8 月發表的一篇論文,與未感染 COVID-19 的女性相比,患有 COVID-19 的女性更容易早產。 這種大流行期間的早產風險預計將推動市場增長。 大流行期間對培養箱的需求增加很可能是由於存儲了 COVID-19 測試樣本。 根據 2021 年 5 月發布的劍橋創新研究所數據,高端微生物學培養箱認識到對 COVID-19 PCR 測試樣本的需求,提供有效熱激活所需的精確溫度控制,並結合了增強實驗室安全性和可用性的先進設計功能。 這種孵化器優勢促成了疫情期間的市場增長。 然而,疫情期間醫院、實驗室等終端用戶已經開始大量購買培養箱。 因此,預計疫情後對孵化器設備的需求將略有下降。 此外,未來幾年對孵化器設備的需求預計會增加,並在未來五年內達到大流行前的水平。
推動孵化器設備市場增長的因素包括早產兒的增加、低出生體重嬰兒的增加以及醫療保健領域研發的進步。
在過去十年中,早產兒的增加增加了對孵化器設備市場的需求。 根據美國疾病預防控制中心 2022 年 5 月發布的一份報告,2021 年美國的早產率為 10.48%。 預計這種早產兒的發生將推動對孵化器設備的需求,並有助於預測期內的市場增長。
產品發布的增加預計也將有助於市場增長。 例如,2021 年 8 月,Thermo Fisher Scientific 將推出一款 CO2 培養箱,它將最佳細胞生長能力與經過認證的潔淨室能力相結合,以滿足生物技術不斷增長的需求。
因此,預計上述因素等因素將有助於預測期內的市場增長。 然而,新興國家的低意識和高孵化器成本預計將在預測期內抑制市場增長。
保育箱設備最常用於兒科醫院、分娩中心和新生兒重症監護室。 醫院被視為培養箱設備製造商的主要最終用戶,因為它們有助於建立品牌形象和擴大產品範圍。 政府為降低嬰兒死亡率和發病率所做的努力促使醫院將重點放在提高生產力上。 這是通過採用先進和創新的醫療設備(包括新生兒保育箱設備)實現的。 例如,2021 年 8 月,印度國家衛生使命啟動了生殖、孕產婦、新生兒和青少年健康 (RMNCH+A) 計劃,旨在到 2025 年將兒童死亡率降至 23%。
此外,預計創新產品的推出將在預測期內推動所研究細分市場的增長。 同樣在 2021 年 9 月,瑞士建築師 Fabien Roy 為撒哈拉以南非洲的一家醫院設計了一個停電培養箱“Robust Nest”,以幫助防止因體溫過低而死亡。
因此,上述因素被認為會推動預測期內的市場增長。
早產人數的增加、發達的醫療保健基礎設施、主要製造商的存在以及先進技術的利用是促進北美孵化器設備市場增長的因素。 根據 2022 年 CDC 更新,到 2021 年,早產將影響美國多達十分之一的嬰兒。 這表明該國早產率很高,這最終將增加對孵化器設備的需求。
此外,預計美國的高醫療保健支出將促進市場的增長。 根據美國醫療保險和醫療補助服務中心 2021 年發布的數據,2020 年美國醫療保健支出將增長 9.7%,達到 4.1 萬億美元。 如此高的醫療保健支出預計將在預測期內促進市場增長。
加拿大的早產率也很高,預計這將推動對孵化器設備的需求。 根據 2021 年 8 月發表的 NCBI 論文,研究隊列中的平均早產率為 7.96%。 另據介紹,安大略省2020年1-12月的早產率為7.87%。 加拿大這種早產率的發生預計將推動該地區的市場增長。
此外,增加產品發布預計也將推動市場增長。 例如,2021 年 8 月,Baker 推出了 ReCO2evr,這是一種新型快速恢復細胞培養物,可為微生物學、細胞培養和生物安全領域的客戶帶來附加價值。
因此,上述因素預計將在預測期內推動市場增長。
孵化器設備市場競爭適中,由幾家大型企業組成。 Andreas Hettich GmbH &Co.KG、Atom Medical Corporation、BMT Medical Technology SRO、Dragerwerk AG &Co.KGaA、GE Healthcare、Medhold Medical (PTY) Ltd、Phoenix Medical Systems (P) Ltd、Thermo Fisher Scientific Inc.等公司持有在孵化器設備市場佔有很大份額。
The incubator devices market is expected to register a CAGR of 6.9% during the forecast period.
COVID-19 significantly impacted the market's growth as the adverse effects caused by COVID-19 and the increase in preterm births drove the demand for incubator devices. As per the article published by JAMA in August 2021, women with COVID-19 were more likely to have preterm birth compared to women without COVID-19. Such risks of preterm birth during the pandemic are expected to drive the market's growth. The increasing demand for incubators during the pandemic period was most likely due to the preservation of test samples for COVID-19. According to the Division of Cambridge Innovation Institute data published in May 2021, recognizing the need for COVID-19 PCR test samples, high-end microbiology incubators provide the precise temperature control necessary for effective heat activation and incorporate advanced design features that enhance laboratory safety and usability. Such benefits offered by incubators contributed to the growth of the market during the pandemic period. However, there were already a large number of incubators acquired by end users, such as hospitals, laboratories, and others, during the pandemic period. Hence, it is expected to have a slight decrease in demand for incubators post-pandemic. Furthermore, the demand for incubators is expected to grow in the coming years and is expected to reach pre-pandemic levels in the next five years.
Certain factors driving the incubator devices market growth include the rising prevalence of premature babies, low birth weight of babies, and growing R&D in healthcare.
In the past decade, the rise in the prevalence of premature babies increased the demand for incubators in the market. According to the CDC report published in May 2022, the preterm birth rate in the United States was 10.48% in 2021. Such incidences of preterm births are expected to drive the demand for incubator devices, thereby contributing to market growth during the forecast period.
Also, increasing product launches are expected to contribute to market growth. For instance, in August 2021, Thermo Fisher Scientific launched a CO2 incubator that combines optimal cell growth capabilities with certified cleanroom capability, addressing the growing need for biotechnology.
Thus, the above-mentioned factors are expected to contribute to the market growth during the forecast period. However, the lack of awareness in emerging economies and the high cost of incubators are expected to restrain the market growth during the forecast period.
An incubator is most commonly used in pediatric hospitals, birthing centers, and neonatal intensive care units. Hospitals are considered major end users by the manufacturers of incubators for selling their products since they help build brand image and expand their product reach. The increasing government focus on reducing infant mortality and morbidity rates has also led hospitals to concentrate on increasing their productivity. This is done by adopting advanced and innovative medical devices, including neonatal incubators. For instance, in August 2021, the National Health Mission, India, launched reproductive, maternal, newborn child, and adolescent health (RMNCH +A) to reduce the infant mortality rate to 23% by 2025.
Additionally, innovative product launches are expected to boost the growth of the studied segment during the forecast period. Also, in September 2021, Swiss architect Fabien Roy designed Robust Nest, an incubator for hospitals in Sub-Saharan Africa that functions through power cuts and was useful for preventing mortality due to hypothermia.
Thus the above-mentioned factors are expected to drive market growth during the forecast period.
The growing number of preterm babies, well-developed healthcare infrastructure, the presence of key manufacturers, and the availability of advanced technologies are factors contributing to the growth of the incubator devices market in North America. According to the CDC update in 2022, preterm births affected about one out of every 10 infants in the United States in 2021. This indicates the high number of preterm births in the country, which ultimately increases the demand for incubator devices.
Additionally, the high healthcare expenditure in the United States is expected to contribute to market growth. According to the data published by the United States Centers for Medicare and Medicaid Services in 2021, United States healthcare spending grew by 9.7% in 2020, reaching USD 4.1 trillion. Such high healthcare spending is expected to contribute to the growth of the market during the forecast period.
Also, the incidence of preterm births in Canada is expected to drive the demand for incubator devices. According to the NCBI article published in August 2021, the mean preterm birth rate for the study cohort was 7.96%. The report also mentioned that from January to December 2020, the preterm birth rate in Ontario was 7.87%. Such an incidence of preterm birth rates in Canada is expected to drive the growth of the market in this region.
Furthermore, the increasing number of product launches is expected to drive the market's growth. For instance, in August 2021, the Baker company launched ReCO2evr, a new rapid recovery cell culture that will bring even more value to its customers in the field of microbiology, cell culture, and biological safety.
Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period.
The incubator devices market is moderately competitive and consists of a few major players. Companies like Andreas Hettich GmbH & Co. KG, Atom Medical Corporation, BMT Medical Technology SRO, Dragerwerk AG & Co. KGaA, GE Healthcare, Medhold Medical (PTY) Ltd, Phoenix Medical Systems (P) Ltd, and Thermo Fisher Scientific Inc., among others, hold the substantial market share in the incubator devices market.